<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04313621</url>
  </required_header>
  <id_info>
    <org_study_id>123456789</org_study_id>
    <nct_id>NCT04313621</nct_id>
  </id_info>
  <brief_title>Management of Lower Limb Apophysitis: A Cross-sectional Study on Long-term Impact on Health Status</brief_title>
  <official_title>Management of Lower Limb Apophysitis: A Cross-sectional Study on Long-term Impact on Health Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lower limb apophysitis cause long-term pain, decrease in function, and can reduce or&#xD;
      completely hinder participation in sports and physical activity, yet there is little&#xD;
      knowledge on the long-term consequences for health. Our objective with this investigation is&#xD;
      to capture self-reported health-status for all adults having been diagnosed with lower limb&#xD;
      apophysitis in the period of 1977 to 2020 and compared these data with normative values for&#xD;
      the background population. We are therefore conducting a national cross-sectional study based&#xD;
      on data from the Danish National Patient Registry. In this protocol we describe, as detailed&#xD;
      as possible, the planned methods.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">April 8, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 22, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Physical and mental health</measure>
    <time_frame>Baseline</time_frame>
    <description>SF-12 (Short-form 12 item) health survey</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep: problems and duration</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported level of satisfaction with participation in physical activity and sports</measure>
    <time_frame>Baseline</time_frame>
    <description>Tegner activity scale (0-10, 10 being no physical activity) and individual specific specific questions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee pain</measure>
    <time_frame>Baseline</time_frame>
    <description>Evaluated on at 0-100 numerical pain rating scale pertaining (0 being no pain) to the knee or other body parts, and worst pain last week or the last month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS subscales</measure>
    <time_frame>Baseline</time_frame>
    <description>Knee injury and Osteoarthritis Outcome Score (KOOS) and its 5 subscale each scoring 0-100, with 100 being the no problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Comorbidities from National Health Survey. and musculoskeletal diagnoses from knee or heel</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PAS-2</measure>
    <time_frame>Baseline</time_frame>
    <description>Physical activtiy scale</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Lower Limb Apophysitis (Severs, Osgood Schlatter, Sinding-Larsen Johansson)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Sample size will be of convenience with no pre-determined cut-off for smallest or largest&#xD;
        sample of interest, rather, the final sample of respondents will be based on however many&#xD;
        have been designated the diagnostic codes and responds to the survey.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients aged 18-55 having received diagnostics codes pertaining to lower limb&#xD;
             apophysitis (Severs, Sinding-Larsen Johansson, Osgood Schlatter) in the years&#xD;
             1977-2020 in Denmark will be eligible to participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diseased participants will be censored&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasper Krommes</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 17, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Kasper Krommes</investigator_full_name>
    <investigator_title>Clinical Research Coordinator, PhD-fellow, Physiotherapist, MSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The full dataset, excluding all personal identifiers, will be posted alongside the pre-print when the results have been disseminated.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>After primary publication and for the foreseeable futures thereafter.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

